- 2008.05.13
- Announcement of Takara Bio's mid-term management plan [New!]
- 2008.04.30
- Start of clinical research of cancer immunotherapy using RetroNectin® expansion culture system at Tianjin Cancer Institute & Hospital, China
- 2008.01.30
- 3rd factory building of Takara Biotechnology (Dalian) Co., Ltd. which is our manufacturing center of research reagents in China has established
- 2008.01.22
- MolMed S.p.A., a strategic partner of Takara Bio in gene therapy, obtains a regulatory approval to start a Phase III trial of HSV-TK gene therapy for high risk acute leukemia in Italy
- 2008.01.09
- Takara Bio to enter into an M-CRADA with Dr. Rosenberg's group at NCI initiating pre-clinical studies of gene therapy using RetroNectin®-expansion culture system
Copyright © 2008 TAKARA BIO INC. All rights reserved.